Evidence map›Paper›PMID 32322591›Full record

ArticleJournal of immunology research2020

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring.

Iole Macchia, Valentina La Sorsa, Irene Ruspantini, Massimo Sanchez, Valentina Tirelli, Maria Carollo, Giorgio Fedele, Pasqualina Leone, Giovanna Schiavoni, Carla Buccione and 21 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Iole MacchiaDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.ORCID https://orcid.org/0000-0002-3870-8202
Valentina La SorsaResearch Coordination and Support Service, CoRI, ISS, Rome 00161, Italy.ORCID https://orcid.org/0000-0002-4141-7561
Irene RuspantiniCore Facilities, ISS, Rome 00161, Italy.
Massimo SanchezCore Facilities, ISS, Rome 00161, Italy.
Valentina TirelliCore Facilities, ISS, Rome 00161, Italy.
Maria CarolloCore Facilities, ISS, Rome 00161, Italy.
Giorgio FedeleDepartment of Infectious Diseases, ISS, Rome 00161, Italy.ORCID https://orcid.org/0000-0003-0017-6711
Pasqualina LeoneDepartment of Infectious Diseases, ISS, Rome 00161, Italy.
Giovanna SchiavoniDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.ORCID https://orcid.org/0000-0001-9135-0556
Carla BuccioneDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.
Paola RizzaCenter for Gender-Specific Medicine, ISS, Rome 00161, Italy.ORCID https://orcid.org/0000-0002-4980-3010
Paola NisticòUnit of Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute (IRE), Rome 00128, Italy.ORCID https://orcid.org/0000-0003-4409-2261
Belinda PalermoUnit of Tumor Immunology and Immunotherapy, IRCCS Regina Elena National Cancer Institute (IRE), Rome 00128, Italy.ORCID https://orcid.org/0000-0001-6293-0113
Stefania MorroneDepartment of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy.ORCID https://orcid.org/0000-0003-2441-9749
Helena StabileDepartment of Molecular Medicine, SUR, Rome 00185, Italy.
Aurelia RughettiDepartment of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy.ORCID https://orcid.org/0000-0002-1863-8251
Marianna NutiDepartment of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy.ORCID https://orcid.org/0000-0003-1809-1003
Ilaria Grazia ZizzariDepartment of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy.ORCID https://orcid.org/0000-0001-8263-7248
Cinzia FiondaDepartment of Molecular Medicine, SUR, Rome 00185, Italy.ORCID https://orcid.org/0000-0003-0636-7607
Roberta MaggioClinical Research, Imperial College, London W12 ONN, UK.ORCID https://orcid.org/0000-0001-8319-4418
Cristina CapuanoDepartment of Experimental Medicine, Sapienza University of Rome (SUR), 00185, Italy.ORCID https://orcid.org/0000-0002-6747-3836
Concetta QuintarelliOnco-Hematology Department, IRCCS Bambino Gesù Children's Hospital (OPBG), Rome 00165, Italy.
Matilde SinibaldiOnco-Hematology Department, IRCCS Bambino Gesù Children's Hospital (OPBG), Rome 00165, Italy.ORCID https://orcid.org/0000-0001-5277-8998
Chiara AgratiCellular Immunology Laboratory, IRCCS National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome 00149, Italy.ORCID https://orcid.org/0000-0002-5252-0927
Rita CasettiCellular Immunology Laboratory, IRCCS National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome 00149, Italy.
Andrea Rozo GonzalezDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.
Floriana IacoboneDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.
Angela GismondiDepartment of Molecular Medicine, SUR, Rome 00185, Italy.
Filippo BelardelliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.
Mauro BiffoniDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.
Francesca UrbaniDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.ORCID https://orcid.org/0000-0002-5522-2706

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersonalised medicine in oncology needs standardised immunological assays. Flow cytometry (FCM) methods represent an essential tool for immunomonitoring, and their harmonisation is crucial to obtain comparable data in multicentre clinical trials. The objective of this study was to design a harmonisation workflow able to address the most effective issues contributing to intra- and interoperator variabilities in a multicentre project.

methodsThe Italian National Institute of Health (Istituto Superiore di Sanità, ISS) managed a multiparametric flow cytometric panel harmonisation among thirteen operators belonging to five clinical and research centres of Lazio region (Italy). The panel was based on a backbone mixture of dried antibodies (anti-CD3, anti-CD4, anti-CD8, anti-CD45RA, and anti-CCR7) to detect naïve/memory T cells, recognised as potential prognostic/predictive immunological biomarkers in cancer immunotherapies. The coordinating centre distributed frozen peripheral blood mononuclear cells (PBMCs) and fresh whole blood (WB) samples from healthy donors, reagents, and Standard Operating Procedures (SOPs) to participants who performed experiments by their own equipment, in order to mimic a real-life scenario. Operators returned raw and locally analysed data to ISS for central analysis and statistical elaboration.

resultsHarmonised and reproducible results were obtained by sharing experimental set-up and procedures along with centralising data analysis, leading to a reduction of cross-centre variability for naïve/memory subset frequencies particularly in the whole blood setting.

conclusionOur experimental and analytical working process proved to be suitable for the harmonisation of FCM assays in a multicentre setting, where high-quality data are required to evaluate potential immunological markers, which may contribute to select better therapeutic options.

Indexed as

BiomarkersCD3 ComplexCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesColorFlow CytometryHumansImmunologic MemoryImmunophenotypingItalyLeukocyte Common AntigensLeukocytes, MononuclearObserver VariationReceptors, CCR7T-Lymphocyte SubsetsBiomarkersCCR7 protein, humanCD3 ComplexLeukocyte Common AntigensReceptors, CCR7

Identifiers

PMID32322591
PMCPMC7153001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.